Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
CA 2435776 A1 · Owner: Molecular Engines Laboratories · Inventors: Telerman, Adam; Amson, Robert; Tuijnder, Marius
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns in particular novel sequences involved in molecular pathways of tumour suppression tumour reversion, apoptosis and/or virus resistance. The invention also concerns the use of said sequences or treatment against cancer viral diseases, neurodegenerative diseases as well as in diagnosis and for implementing screening methods for compounds to be tested. The invention further concerns methods for detection and/or assay of the inventive sequences or of their expression products in a biological sample.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.